Allergy Immunotherapy Market Forecasts to 2028 – Global Analysis By Allergy Type (Allergic Asthma, Allergic Rhinitis and Others), Allergen (House Dust Mites, Mould and Others) Treatment Type, Distribution Channel and By Geography
According to Stratistics MRC, the Global Allergy Immunotherapy Market is accounted for $1.74 billion in 2020 and is expected to reach $4.02 billion by 2028 growing at a CAGR of 11.0% during the forecast period. Advancements in sublingual immunotherapy formulations, growth in the prevalence of allergic disorders and strong product pipeline for novel approaches of treatments are driving the market growth. However, limitation and drawback associated with the use of allergy immunotherapy is hampering the growth of the market.
Allergy immunotherapy is a protective medical treatment for allergic reactions to allergens including various drugs, house dust mites, foods, bee venom and grass pollens. It regulates the response of immune system by gradually increasing the doses of the allergen. This process is also termed as desensitization or hypo-sensitization.
Based on the treatment type, the subcutaneous immunotherapy (SCIT) (specific immunotherapy (SIT)) segment is going to have lucrative growth during the forecast period due to its cost effectiveness and ease of availability of allergy shots. Surge in prevalence of asthma and insect sting allergies are also factors contributing to the growth of segment.
By geography, Europe is going to have high growth during the forecast period as it is a home to a large patient pool which is prone to allergies and thus requires high medical attention. Furthermore, the mount in the instances of approvals of allergy drops will further catapult the progression of the market.
Some of the key players profiled in the Allergy Immunotherapy Market include Adamis, Pharmaceuticals Corporation, ALK-Abello A/S, Allergy Therapeutics, ASIT Biotech, Circassia, DBV Technologies SA, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, Merck KGaA, Mylan N.V. and Stallergenes Greer plc.
Allergy Types Covered:
All the customers of this report will be entitled to receive one of the following free customization options:
Allergy immunotherapy is a protective medical treatment for allergic reactions to allergens including various drugs, house dust mites, foods, bee venom and grass pollens. It regulates the response of immune system by gradually increasing the doses of the allergen. This process is also termed as desensitization or hypo-sensitization.
Based on the treatment type, the subcutaneous immunotherapy (SCIT) (specific immunotherapy (SIT)) segment is going to have lucrative growth during the forecast period due to its cost effectiveness and ease of availability of allergy shots. Surge in prevalence of asthma and insect sting allergies are also factors contributing to the growth of segment.
By geography, Europe is going to have high growth during the forecast period as it is a home to a large patient pool which is prone to allergies and thus requires high medical attention. Furthermore, the mount in the instances of approvals of allergy drops will further catapult the progression of the market.
Some of the key players profiled in the Allergy Immunotherapy Market include Adamis, Pharmaceuticals Corporation, ALK-Abello A/S, Allergy Therapeutics, ASIT Biotech, Circassia, DBV Technologies SA, DESENTUM OY, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, Merck KGaA, Mylan N.V. and Stallergenes Greer plc.
Allergy Types Covered:
- Allergic Asthma
- Allergic Conjunctivitis
- Allergic Rhinitis
- Atopic Dermatitis
- Food Allergy
- Pet Allergy
- Venom Allergy
- Other Allergy Types
- House Dust Mites
- Mould
- Pollens
- Stinging Insect Venom
- Animal Dander
- Cockroaches/Insects
- Subcutaneous Immunotherapy (SCIT) (Specific Immunotherapy (SIT))
- Sublingual Immunotherapy (SLIT)
- Institutional Sales
- Retail Sales
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
1 EXECUTIVE SUMMARY
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY ALLERGY TYPE
5.1 Introduction
5.2 Allergic Asthma
5.3 Allergic Conjunctivitis
5.4 Allergic Rhinitis
5.5 Atopic Dermatitis
5.6 Food Allergy
5.7 Pet Allergy
5.8 Venom Allergy
5.9 Other Allergy Types
5.9.1 Drug Allergy
5.9.2 Eye Allergy
5.9.3 Latex Allergy
5.9.4 Skin Allergy
6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY ALLERGEN
6.1 Introduction
6.2 House Dust Mites
6.3 Mould
6.4 Pollens
6.4.1 Grass Pollens
6.4.2 Weed Pollens
6.4.3 Tree Pollens
6.5 Stinging Insect Venom
6.6 Animal Dander
6.7 Cockroaches/Insects
7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT TYPE
7.1 Introduction
7.2 Subcutaneous Immunotherapy (SCIT) (Specific Immunotherapy (SIT))
7.3 Sublingual Immunotherapy (SLIT)
7.3.1 Drops
7.3.2 Tablets
7.3.2.1 Actair
7.3.2.2 Grastek
7.3.2.3 Odactra
7.3.2.4 Oralair
7.3.2.5 Ragwitek
7.3.3 Injections
7.3.4 Oral (Palforzia)
8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
8.1 Introduction
8.2 Institutional Sales
8.2.1 Government Hospitals
8.2.2 Private Hospitals
8.2.3 Semi-Government Hospitals
8.3 Retail Sales
8.3.1 Drug Stores
8.3.2 Online Pharmacy
8.3.3 Retail Pharmacy
9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Adamis Pharmaceuticals Corporation
11.2 ALK-Abello A/S
11.3 Allergy Therapeutics
11.4 ASIT Biotech
11.5 Circassia
11.6 DBV Technologies SA
11.7 DESENTUM OY
11.8 HAL Allergy B.V.
11.9 HollisterStier Allergy
11.10 LETIPharma
11.11 Merck KGaA
11.12 Mylan N.V.
11.13 Stallergenes Greer plc
2 PREFACE
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 MARKET TREND ANALYSIS
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Emerging Markets
3.7 Impact of Covid-19
4 PORTERS FIVE FORCE ANALYSIS
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY ALLERGY TYPE
5.1 Introduction
5.2 Allergic Asthma
5.3 Allergic Conjunctivitis
5.4 Allergic Rhinitis
5.5 Atopic Dermatitis
5.6 Food Allergy
5.7 Pet Allergy
5.8 Venom Allergy
5.9 Other Allergy Types
5.9.1 Drug Allergy
5.9.2 Eye Allergy
5.9.3 Latex Allergy
5.9.4 Skin Allergy
6 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY ALLERGEN
6.1 Introduction
6.2 House Dust Mites
6.3 Mould
6.4 Pollens
6.4.1 Grass Pollens
6.4.2 Weed Pollens
6.4.3 Tree Pollens
6.5 Stinging Insect Venom
6.6 Animal Dander
6.7 Cockroaches/Insects
7 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY TREATMENT TYPE
7.1 Introduction
7.2 Subcutaneous Immunotherapy (SCIT) (Specific Immunotherapy (SIT))
7.3 Sublingual Immunotherapy (SLIT)
7.3.1 Drops
7.3.2 Tablets
7.3.2.1 Actair
7.3.2.2 Grastek
7.3.2.3 Odactra
7.3.2.4 Oralair
7.3.2.5 Ragwitek
7.3.3 Injections
7.3.4 Oral (Palforzia)
8 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
8.1 Introduction
8.2 Institutional Sales
8.2.1 Government Hospitals
8.2.2 Private Hospitals
8.2.3 Semi-Government Hospitals
8.3 Retail Sales
8.3.1 Drug Stores
8.3.2 Online Pharmacy
8.3.3 Retail Pharmacy
9 GLOBAL ALLERGY IMMUNOTHERAPY MARKET, BY GEOGRAPHY
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 KEY DEVELOPMENTS
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 COMPANY PROFILING
11.1 Adamis Pharmaceuticals Corporation
11.2 ALK-Abello A/S
11.3 Allergy Therapeutics
11.4 ASIT Biotech
11.5 Circassia
11.6 DBV Technologies SA
11.7 DESENTUM OY
11.8 HAL Allergy B.V.
11.9 HollisterStier Allergy
11.10 LETIPharma
11.11 Merck KGaA
11.12 Mylan N.V.
11.13 Stallergenes Greer plc
LIST OF TABLES
Table 1 Global Allergy Immunotherapy Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Allergy Immunotherapy Market Outlook, By Allergy Type (2019-2028) (US $MN)
Table 3 Global Allergy Immunotherapy Market Outlook, By Allergic Asthma (2019-2028) (US $MN)
Table 4 Global Allergy Immunotherapy Market Outlook, By Allergic Conjunctivitis (2019-2028) (US $MN)
Table 5 Global Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2019-2028) (US $MN)
Table 6 Global Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2019-2028) (US $MN)
Table 7 Global Allergy Immunotherapy Market Outlook, By Food Allergy (2019-2028) (US $MN)
Table 8 Global Allergy Immunotherapy Market Outlook, By Pet Allergy (2019-2028) (US $MN)
Table 9 Global Allergy Immunotherapy Market Outlook, By Venom Allergy (2019-2028) (US $MN)
Table 10 Global Allergy Immunotherapy Market Outlook, By Other Allergy Types (2019-2028) (US $MN)
Table 11 Global Allergy Immunotherapy Market Outlook, By Drug Allergy (2019-2028) (US $MN)
Table 12 Global Allergy Immunotherapy Market Outlook, By Eye Allergy (2019-2028) (US $MN)
Table 13 Global Allergy Immunotherapy Market Outlook, By Latex Allergy (2019-2028) (US $MN)
Table 14 Global Allergy Immunotherapy Market Outlook, By Skin Allergy (2019-2028) (US $MN)
Table 15 Global Allergy Immunotherapy Market Outlook, By Allergen (2019-2028) (US $MN)
Table 16 Global Allergy Immunotherapy Market Outlook, By Cockroaches/Insects (2019-2028) (US $MN)
Table 17 Global Allergy Immunotherapy Market Outlook, By House Dust Mites (2019-2028) (US $MN)
Table 18 Global Allergy Immunotherapy Market Outlook, By Mould (2019-2028) (US $MN)
Table 19 Global Allergy Immunotherapy Market Outlook, By Pollens (2019-2028) (US $MN)
Table 20 Global Allergy Immunotherapy Market Outlook, By Grass Pollens (2019-2028) (US $MN)
Table 21 Global Allergy Immunotherapy Market Outlook, By Weed Pollens (2019-2028) (US $MN)
Table 22 Global Allergy Immunotherapy Market Outlook, By Tree Pollens (2019-2028) (US $MN)
Table 23 Global Allergy Immunotherapy Market Outlook, By Stinging Insect Venom (2019-2028) (US $MN)
Table 24 Global Allergy Immunotherapy Market Outlook, By Animal Dander (2019-2028) (US $MN)
Table 25 Global Allergy Immunotherapy Market Outlook, By Cockroaches/Insects (2019-2028) (US $MN)
Table 26 Global Allergy Immunotherapy Market Outlook, By Treatment Type (2019-2028) (US $MN)
Table 27 Global Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (SCIT) (Specific Immunotherapy (SIT)) (2019-2028) (US $MN)
Table 28 Global Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (SLIT) (2019-2028) (US $MN)
Table 29 Global Allergy Immunotherapy Market Outlook, By Drops (2019-2028) (US $MN)
Table 30 Global Allergy Immunotherapy Market Outlook, By Tablets (2019-2028) (US $MN)
Table 31 Global Allergy Immunotherapy Market Outlook, By Actair (2019-2028) (US $MN)
Table 32 Global Allergy Immunotherapy Market Outlook, By Grastek (2019-2028) (US $MN)
Table 33 Global Allergy Immunotherapy Market Outlook, By Odactra (2019-2028) (US $MN)
Table 34 Global Allergy Immunotherapy Market Outlook, By Oralair (2019-2028) (US $MN)
Table 35 Global Allergy Immunotherapy Market Outlook, By Ragwitek (2019-2028) (US $MN)
Table 36 Global Allergy Immunotherapy Market Outlook, By Injections (2019-2028) (US $MN)
Table 37 Global Allergy Immunotherapy Market Outlook, By Oral (Palforzia) (2019-2028) (US $MN)
Table 38 Global Allergy Immunotherapy Market Outlook, By Distribution Channel (2019-2028) (US $MN)
Table 39 Global Allergy Immunotherapy Market Outlook, By Institutional Sales (2019-2028) (US $MN)
Table 40 Global Allergy Immunotherapy Market Outlook, By Government Hospitals (2019-2028) (US $MN)
Table 41 Global Allergy Immunotherapy Market Outlook, By Private Hospitals (2019-2028) (US $MN)
Table 42 Global Allergy Immunotherapy Market Outlook, By Semi-Government Hospitals (2019-2028) (US $MN)
Table 43 Global Allergy Immunotherapy Market Outlook, By Retail Sales (2019-2028) (US $MN)
Table 44 Global Allergy Immunotherapy Market Outlook, By Drug Stores (2019-2028) (US $MN)
Table 45 Global Allergy Immunotherapy Market Outlook, By Online Pharmacy (2019-2028) (US $MN)
Table 46 Global Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2019-2028) (US $MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
Table 1 Global Allergy Immunotherapy Market Outlook, By Region (2019-2028) (US $MN)
Table 2 Global Allergy Immunotherapy Market Outlook, By Allergy Type (2019-2028) (US $MN)
Table 3 Global Allergy Immunotherapy Market Outlook, By Allergic Asthma (2019-2028) (US $MN)
Table 4 Global Allergy Immunotherapy Market Outlook, By Allergic Conjunctivitis (2019-2028) (US $MN)
Table 5 Global Allergy Immunotherapy Market Outlook, By Allergic Rhinitis (2019-2028) (US $MN)
Table 6 Global Allergy Immunotherapy Market Outlook, By Atopic Dermatitis (2019-2028) (US $MN)
Table 7 Global Allergy Immunotherapy Market Outlook, By Food Allergy (2019-2028) (US $MN)
Table 8 Global Allergy Immunotherapy Market Outlook, By Pet Allergy (2019-2028) (US $MN)
Table 9 Global Allergy Immunotherapy Market Outlook, By Venom Allergy (2019-2028) (US $MN)
Table 10 Global Allergy Immunotherapy Market Outlook, By Other Allergy Types (2019-2028) (US $MN)
Table 11 Global Allergy Immunotherapy Market Outlook, By Drug Allergy (2019-2028) (US $MN)
Table 12 Global Allergy Immunotherapy Market Outlook, By Eye Allergy (2019-2028) (US $MN)
Table 13 Global Allergy Immunotherapy Market Outlook, By Latex Allergy (2019-2028) (US $MN)
Table 14 Global Allergy Immunotherapy Market Outlook, By Skin Allergy (2019-2028) (US $MN)
Table 15 Global Allergy Immunotherapy Market Outlook, By Allergen (2019-2028) (US $MN)
Table 16 Global Allergy Immunotherapy Market Outlook, By Cockroaches/Insects (2019-2028) (US $MN)
Table 17 Global Allergy Immunotherapy Market Outlook, By House Dust Mites (2019-2028) (US $MN)
Table 18 Global Allergy Immunotherapy Market Outlook, By Mould (2019-2028) (US $MN)
Table 19 Global Allergy Immunotherapy Market Outlook, By Pollens (2019-2028) (US $MN)
Table 20 Global Allergy Immunotherapy Market Outlook, By Grass Pollens (2019-2028) (US $MN)
Table 21 Global Allergy Immunotherapy Market Outlook, By Weed Pollens (2019-2028) (US $MN)
Table 22 Global Allergy Immunotherapy Market Outlook, By Tree Pollens (2019-2028) (US $MN)
Table 23 Global Allergy Immunotherapy Market Outlook, By Stinging Insect Venom (2019-2028) (US $MN)
Table 24 Global Allergy Immunotherapy Market Outlook, By Animal Dander (2019-2028) (US $MN)
Table 25 Global Allergy Immunotherapy Market Outlook, By Cockroaches/Insects (2019-2028) (US $MN)
Table 26 Global Allergy Immunotherapy Market Outlook, By Treatment Type (2019-2028) (US $MN)
Table 27 Global Allergy Immunotherapy Market Outlook, By Subcutaneous Immunotherapy (SCIT) (Specific Immunotherapy (SIT)) (2019-2028) (US $MN)
Table 28 Global Allergy Immunotherapy Market Outlook, By Sublingual Immunotherapy (SLIT) (2019-2028) (US $MN)
Table 29 Global Allergy Immunotherapy Market Outlook, By Drops (2019-2028) (US $MN)
Table 30 Global Allergy Immunotherapy Market Outlook, By Tablets (2019-2028) (US $MN)
Table 31 Global Allergy Immunotherapy Market Outlook, By Actair (2019-2028) (US $MN)
Table 32 Global Allergy Immunotherapy Market Outlook, By Grastek (2019-2028) (US $MN)
Table 33 Global Allergy Immunotherapy Market Outlook, By Odactra (2019-2028) (US $MN)
Table 34 Global Allergy Immunotherapy Market Outlook, By Oralair (2019-2028) (US $MN)
Table 35 Global Allergy Immunotherapy Market Outlook, By Ragwitek (2019-2028) (US $MN)
Table 36 Global Allergy Immunotherapy Market Outlook, By Injections (2019-2028) (US $MN)
Table 37 Global Allergy Immunotherapy Market Outlook, By Oral (Palforzia) (2019-2028) (US $MN)
Table 38 Global Allergy Immunotherapy Market Outlook, By Distribution Channel (2019-2028) (US $MN)
Table 39 Global Allergy Immunotherapy Market Outlook, By Institutional Sales (2019-2028) (US $MN)
Table 40 Global Allergy Immunotherapy Market Outlook, By Government Hospitals (2019-2028) (US $MN)
Table 41 Global Allergy Immunotherapy Market Outlook, By Private Hospitals (2019-2028) (US $MN)
Table 42 Global Allergy Immunotherapy Market Outlook, By Semi-Government Hospitals (2019-2028) (US $MN)
Table 43 Global Allergy Immunotherapy Market Outlook, By Retail Sales (2019-2028) (US $MN)
Table 44 Global Allergy Immunotherapy Market Outlook, By Drug Stores (2019-2028) (US $MN)
Table 45 Global Allergy Immunotherapy Market Outlook, By Online Pharmacy (2019-2028) (US $MN)
Table 46 Global Allergy Immunotherapy Market Outlook, By Retail Pharmacy (2019-2028) (US $MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
